Multiple sclerosis (MS), a complex autoimmune disorder affecting the central nervous system, remains significantly underdiagnosed in India. Contributing factors include limited awareness among healthcare professionals and the public, inadequate diagnostic infrastructure, and restricted access to specialized neurologists. This delay in diagnosis often results in worsened patient outcomes and increased long-term healthcare costs. Addressing these challenges requires comprehensive reforms spanning medical education, investment in diagnostic technologies, and public health initiatives.